ArticleScientific reports2026
Effect of the biologically synthesized rGO NPs and Fe
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Biologically synthesized reduced graphene oxide nanoparticles (rGO NPs) and Fe₂O₃/rGO nanocomposites (NCs) were evaluated for their effects on growth and phytochemical responses of Achillea millefolium regenerated shoot cultures. rGO NPs exhibited in vitro cytotoxicity but did not significantly affect overall growth parameters. In contrast, Fe₂O₃/rGO NCs selectively enhanced root elongation at 20 mg/L, indicating a dose-dependent stimulatory response. Both nanomaterials (NMs) caused a reduction in photosynthetic pigment levels. Phytochemical analysis revealed a pronounced increase in volatile metabolite profiles in treated cultures, with Fe₂O₃/rGO NCs showing stronger elicitation than rGO NPs. The highest accumulation of volatile metabolites was observed at 40 mg/L Fe₂O₃/rGO NCs. These findings suggest that Fe₂O₃/rGO NCs, at optimized concentrations, can function as effective elicitors for in vitro enhancement of secondary metabolite production in A. millefolium.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.